MYC and pachyonychia congenita: Although associated with PC progression and a potential target for therapeutic intervention, c-Myc is not readily targetable due to a disordered tertiary helical structure, inaccessibility to the drug due to the predominant nuclear localization, and difficulty with targeted degradation [2,3,4].